Stealth BioTherapeutics Corp
Methods for the regulation of matrix metalloproteinase expression

Last updated:

Abstract:

The disclosure provides methods of reducing MMP-9 expression and/or MMP-9 activity in a mammalian subject. The disclosure also provides methods of increasing TIMP-1 expression and/or TIMP-1 activity in a mammalian subject. The methods comprise administering a therapeutically effective amount of an aromatic-cationic peptide to a subject in need thereof.

Status:
Grant
Type:

Utility

Filling date:

2 Dec 2019

Issue date:

8 Mar 2022